0 C°
Traffic jam:   0


Chief Financial Officer at Altimmune

Organization: Altimmune

Profession: Chief financial officer



Richard Eisenstadt is Chief Financial Officer at Altimmune.


Mr. Eisenstadt has served as Chief Financial Officer of Altimmune since December 2021. He has served in senior financial leadership roles for over twenty-five years. Prior to joining Altimmune, he served as Chief Financial Officer at Aytu BioPharma, Inc. following its merger with Neos Therapeutics, Inc. in March 2021.

While Chief Financial Officer at Neos, he raised over $340 million in private and public equity and debt financings and supported the transition of the company from clinical stage to commercial operations. Prior to Neos, Mr. Eisenstadt served as Chief Financial Officer at Arborgen, Inc., and prior to that, Chief Financial Officer at Tranzyme, Inc., where he was instrumental in its initial public offering, negotiating several licensing agreements, and financing the company through late-stage clinical development.


Mr. Eisenstadt received an M.B.A. from James Madison University and a B.A. in Economics from the University of North Carolina at Chapel Hill.

Rating GlobalNY.biz

Takes place
Takes place
In rating
Takes place

Mentioned together

Former Chief Financial Officer at Twitter
1 place
Chief Financial Officer at BlackRock
2 place
Chief financial officer at Apple
3 place
Chief Finance and Administrative Officer at The Sisters of Notre Dame of the United States
4 place
Chief financial officer of Walt Disney Company
5 place
Chief Financial Officer of Liquidia Corporation
6 place
Chief Financial Officer at Marinus Pharmaceuticals
7 place
Chief Financial Officer at General Mills
8 place
Chief Financial Officer at Nuvve Holding
9 place
Chief Financial Officer at Nano Dimension
10 place
Chief Financial Officer at Alibaba Group
11 place
Chief Financial Officer at Public Storage
12 place
Chief Financial Officer at JPMorgan Chase
13 place
Chief Financial Officer of Spotify
14 place
Chief Financial Officer at The Hartford Financial Services Group
15 place


President and Chief Executive Officer at Altimmune
1 place
Chief Scientific Officer at Altimmune
2 place
Chief Medical Officer of Altimmune
3 place
Chief Technology Officer of Altimmune
4 place
Chief Business Officer at Altimmune
5 place


Profile statistic

Companies rating
Morgan Stanley
19 Persons
19 Persons
White House
16 Persons
United States House of Representatives
16 Persons
15 Persons
Foot Locker
14 Persons
13 Persons
Stran & Company
13 Persons
United States Senate
12 Persons
General Mills
12 Persons
GlobalNY.biz pays special attention to the activities of famous people: politicians, officials, businessmen, bankers, cultural and sports figures. Their opinion largely determines the development of political, social and economic life in New York. The section is constantly edited by our journalists for the relevance of information. Here you can find information about CEOs and presidents of top New York companies, officials and public figures who play a key role in the development of the region.
The goal of the project is to create a comfortable information space for all market actors, as well as to acquaint the readership with business people in New York.
We have created an impressive database of people in New York, which contains information about a career path, education and other important information about a person.
Thanks to automatic counting of the number of mentions of a person in the news sections " New York News ”and“ New York Press Releases ”on the portal the rating of popularity and influence of persons is formed. The GlobalNY.biz team monitors rating changes and rewards project participants for their success. In general, the rating of participants is based on an in-depth analysis of the activity of PR services of famous people, and also reflects the qualitative state of the information field formed by the media and press services around the organization.
Business People of New York is a project about people who, through their ideas, words and deeds, have a great influence on the development and prosperity of New York.
Alena Potapova

Development Director
Died this year
Born this year